What is the share price of Starsource Multitrade Ltd (CHEMOPH) today?
The share price of CHEMOPH as on 31st October 2025 is ₹129. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Starsource Multitrade Ltd (CHEMOPH) share?
The past returns of Starsource Multitrade Ltd (CHEMOPH) share are- Past 1 week: -6.58%
- Past 1 month: 1.17%
- Past 3 months: 4.43%
- Past 6 months: 1.67%
- Past 1 year: 74.51%
- Past 3 years: 244.34%
- Past 5 years: 656.36%
What are the peers or stocks similar to Starsource Multitrade Ltd (CHEMOPH)?
The peers or stocks similar to Starsource Multitrade Ltd (CHEMOPH) include:What is the market cap of Starsource Multitrade Ltd (CHEMOPH) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Starsource Multitrade Ltd (CHEMOPH) is ₹19.63 Cr as of 31st October 2025.What is the 52 week high and low of Starsource Multitrade Ltd (CHEMOPH) share?
The 52-week high of Starsource Multitrade Ltd (CHEMOPH) is ₹154 and the 52-week low is ₹63.05.What is the PE and PB ratio of Starsource Multitrade Ltd (CHEMOPH) stock?
The P/E (price-to-earnings) ratio of Starsource Multitrade Ltd (CHEMOPH) is 59.48. The P/B (price-to-book) ratio is 1.49.Which sector does Starsource Multitrade Ltd (CHEMOPH) belong to?
Starsource Multitrade Ltd (CHEMOPH) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Starsource Multitrade Ltd (CHEMOPH) shares?
You can directly buy Starsource Multitrade Ltd (CHEMOPH) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Starsource Multitrade Ltd
CHEMOPH Share Price
129.0010.87% (+12.65)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
CHEMOPH Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
CHEMOPH Performance & Key Metrics
CHEMOPH Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -1.68 | 1.49 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.93 | 5.82 | 0.59% |
CHEMOPH Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
CHEMOPH Company Profile
Chemo Pharma Laboratories Limited is in negotiation to some other company and rehab to acquire business in power and chemicals. The Company was engaged in pharmaceuticals and bulk drugs business.
SUNPHARMA
PE Ratio
37.12
37.12
1Y Return
8.56%
8.56%
Buy Reco %
86.11
86.11
CIPLA
PE Ratio
23.00
23.00
1Y Return
3.25%
3.25%
Buy Reco %
68.75
68.75
TORNTPHARM
PE Ratio
63.04
63.04
1Y Return
11.16%
11.16%
Buy Reco %
72.00
72.00
DRREDDY
PE Ratio
17.63
17.63
1Y Return
6.01%
6.01%
Buy Reco %
41.94
41.94
MANKIND
PE Ratio
49.42
49.42
1Y Return
10.62%
10.62%
Buy Reco %
81.25
81.25
CHEMOPH Forecast
CHEMOPH Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
CHEMOPH
CHEMOPH
Income
Balance Sheet
Cash Flow
Annual Normal View
CHEMOPH Income Statement
CHEMOPH Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5.61 | 1.11 | 0.82 | 1.00 | 0.67 | 0.79 | 0.30 | 1.84 | 0.62 | 0.34 | ||||||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.89 | ||||||||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.03 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Employee Cost | 0.06 | 0.13 | 0.21 | 0.15 | 0.09 | 0.14 | 0.07 | 0.02 | 0.02 | |||||||||||
| Selling & Administrative Expenses | 0.16 | 0.21 | 0.30 | 0.26 | 0.16 | 0.22 | 0.13 | 0.16 | 0.09 | |||||||||||
| Operating & Other expenses | 0.05 | 0.00 | 0.02 | 0.05 | 0.08 | 0.04 | 0.00 | 0.00 | 0.01 | |||||||||||
EBITDA | 5.34 | 0.77 | 0.26 | 0.52 | 0.34 | 0.39 | 0.10 | 1.66 | 0.50 | -11.55 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | — | ||||||||||
| PBIT | 5.34 | 0.77 | 0.26 | 0.50 | 0.32 | 0.37 | 0.09 | 1.65 | 0.49 | -11.55 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | — | ||||||||||
| PBT | 5.34 | 0.77 | 0.26 | 0.50 | 0.32 | 0.37 | 0.08 | 1.65 | 0.49 | -11.55 | ||||||||||
| Taxes & Other Items | 0.65 | 0.66 | 0.05 | 0.08 | 0.06 | -0.20 | 0.03 | 0.44 | 0.16 | 0.16 | ||||||||||
| Net Income | 4.69 | 0.11 | 0.21 | 0.42 | 0.26 | 0.57 | 0.05 | 1.21 | 0.33 | -11.71 | ||||||||||
| EPS | 31.27 | 0.73 | 1.40 | 2.80 | 1.73 | 3.80 | 0.33 | 8.07 | 2.20 | -78.07 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CHEMOPH Company Updates
CHEMOPH Stock Peers
CHEMOPH Past Performance & Peer Comparison
CHEMOPH Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Starsource Multitrade Ltd | 59.48 | 1.49 | — |
| Sun Pharmaceutical Industries Ltd | 37.12 | 5.60 | 0.95% |
| Cipla Ltd | 23.00 | 3.88 | 1.07% |
| Torrent Pharmaceuticals Ltd | 63.04 | 15.87 | 0.90% |
CHEMOPH Stock Price Comparison
Compare CHEMOPH with any stock or ETFCompare CHEMOPH with any stock or ETF
CHEMOPH
CHEMOPH Holdings
CHEMOPH Shareholdings
CHEMOPH Promoter Holdings Trend
CHEMOPH Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
CHEMOPH Institutional Holdings Trend
CHEMOPH Institutional Holdings Trend
Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has decreased by 1.61%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
CHEMOPH Shareholding Pattern
CHEMOPH Shareholding Pattern
CHEMOPH Shareholding History
CHEMOPH Shareholding History
Foreign Institutions
smallcases containing CHEMOPH stock
smallcases containing CHEMOPH stock
Looks like this stock is not in any smallcase yet.
CHEMOPH Events
CHEMOPH Events
CHEMOPH Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
CHEMOPH has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
CHEMOPH Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
CHEMOPH has not given any dividends in last 5 years
CHEMOPH Dividends
CHEMOPH Dividends
Hmm, looks like data is unavailable here. Please come back after some timeCHEMOPH Stock News & Opinions
CHEMOPH Stock News & Opinions
Articles & Videos
Corporate
Chemo Pharma Laboratories AGM scheduled
Chemo Pharma Laboratories announced that the 83th Annual General Meeting(AGM) of the company will be held on 24 September 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Chemo Pharma Laboratories announces board meeting date
Chemo Pharma Laboratories will hold a meeting of the Board of Directors of the Company on 22 August 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Chemo Pharma Laboratories reports standalone net loss of Rs 11.81 crore in the June 2025 quarter
Net loss of Chemo Pharma Laboratories reported to Rs 11.81 crore in the quarter ended June 2025 as against net profit of Rs 0.25 crore during the previous quarter ended June 2024. There were no Sales reported in the quarter ended June 2025 and during the previous quarter ended June 2024.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Chemo Pharma Laboratories to announce Quarterly Result
Chemo Pharma Laboratories will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Chemo Pharma Laboratories to convene board meeting
Chemo Pharma Laboratories will hold a meeting of the Board of Directors of the Company on 31 July 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Chemo Pharma Laboratories reports standalone net loss of Rs 0.34 crore in the March 2025 quarter
Net Loss of Chemo Pharma Laboratories reported to Rs 0.34 crore in the quarter ended March 2025 as against net loss of Rs 0.29 crore during the previous quarter ended March 2024. There were no Sales reported in the quarter ended March 2025 and during the previous quarter ended March 2024. For the full year,net profit declined 71.67% to Rs 0.34 crore in the year ended March 2025 as against Rs 1.20 crore during the previous year ended March 2024. There were no Sales reported in the year ended March 2025 and during the previous year ended March 2024.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Chemo Pharma Laboratories to convene board meeting
Chemo Pharma Laboratories will hold a meeting of the Board of Directors of the Company on 29 May 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Chemo Pharma Laboratories to conduct board meeting
Chemo Pharma Laboratories will hold a meeting of the Board of Directors of the Company on 16 April 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Chemo Pharma Laboratories reports standalone net loss of Rs 0.17 crore in the December 2024 quarter
Net loss of Chemo Pharma Laboratories reported to Rs 0.17 crore in the quarter ended December 2024 as against net profit of Rs 0.68 crore during the previous quarter ended December 2023. There were no Sales reported in the quarter ended December 2024 and during the previous quarter ended December 2023.Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Chemo Pharma Laboratories to table results
Chemo Pharma Laboratories will hold a meeting of the Board of Directors of the Company on 27 January 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -9.12%, vs industry avg of 9.98%
Over the last 5 years, market share stayed at 0%
Over the last 5 years, net income has grown at a yearly rate of -4.71%, vs industry avg of 20.01%